Drive Biomarker Adoption And Precision Oncology Across Your Brands
- Understand the diagnostic landscape and gain insights with account and provider segmentation
- Identify provider ordering and prescribing signals in real-time using lab, EMR and genomics data
- Collaborate with our commercial and medical teams to drive biomarker testing to under-served populations
REAL-WORLD INSIGHTS
Comprised of more than 1.9M patient profiles, NeoGenomics clinico-genomic database can help you:
- Track biomarker-testing trends and disease relevance to assess commercial potential
- Interrogate unique patient cohorts for health economics and outcomes research
- Build deep and insightful patient journeys that may elevate your commercial planning
Download the Lite Paper
Using Real-World Lab Data Insights to Improve Biomarker Testing in Lung Cancer
TRIGGERS, LAB ALERTS, DIGITAL SIGNALS
Results that matter right when you need them
- Maximize the impact of your diagnostic and therapeutic teams can have by communicating the right message to the right provider at the right time
- Integrate digital signals directly into your data warehouse or CRM application to support commercial activities
- Execute brand specific sales and marketing campaigns around specific personas or customer segments using near-real time lab, EMR and genomics data
SPONSORED TESTING PROGRAMS
Exclusive to NeoGenomics
- Leverage one of the largest menus of oncology LDTs and CDx assays to accelerate your testing programs and efforts
- Integrate triggers, lab alerts and digital signals with sponsored testing to bring the right diagnostic testing message, to the right provider, at the right time
- Power future observational studies by integrating sponsored testing programs into a registry and longitudinal follow-up of unique patient populations